CBSET, Inc
CBSET Literature
2006

  • Methe, H, Edelman ER. Cell-matrix contact prevents recognition and damage of endothelial cells in states of heightened immunity. Circulation 2006 July 4; 114:1233-1238.
  • Richter Y, Edelman, ER. Cardiology Is Flow. Circulation 2006 June 13;113:2679-2682.
  • Rogers C, Edelman ER. Pushing Drug-Eluting Stents Into Uncharted Territory. Simpler Than You Think--More Complex Than You Imagine. Circulation 2006 May 16; 113:2262-2265.
  • Costa LF, Balcells M, Edelman ER, Nadler LM, Cardoso AA. Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockage of mTOR and NF-(kappa)B. Blood. 2006 107(1): 285-292.
  • Jonas M, Fang JC, Wang JC, Giri S, Elian D, Har-Zahav Y, Ly H, Seifert PA, Popma JJ, Rogers C. In-Stent Restenosis and Remote Coronary Lesion Progression Are Coupled in Cardiac Transplant Vasculopathy But Not in Native Coronary Artery Disease. Journal of the American College of Cardiology 2006 July 26; 48(3): 453-461.
2005

  • Levin AD, Jonas M, Hwang CW, Edelman ER. Local and systematic drug competition in drug-eluting stent tissue deposition properties. J Controlled Release. 2005 Aug 15;109:236-243.
  • Methe H, Nugent HM, Groothuis A, Seifert P, Sayegh MH, Edelman, ER. Matrix Embedding Alters the Immune Response Against Endothelial Cells In Vitro and In Vivo. Circulation 2005 Aug 30;112:189-195.
  • Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C. Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res. 2005 Sep 30;97(7):725-33. Epub 2005 Aug 25
  • Methe H, Brunner S, Wiegand D, Nabauer M, Koglin J, Edelman ER. T-Helper-1 Lymphocyte Activation Patterns in Acute Coronary Syndromes. J Am Coll Cardiol. 2005 Jun 21;45(12):1939-1945.
  • Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation 2005 Jun 7;111(22):2958-65.
  • Hwang CW, Levin AD, Jonas M, Li PH, Edelman ER. Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation 2005 Apr 5;111(13):1619-26.
  • Tzafriri AR , Edelman ER. On the validity of the quasi-steady state approximation of bimolecular reactions in solution. Journal of Theoretical Biology. 2005 Apr 7;233(2):343-350.
  • Balcells M, Fernandez MS, Vazquez M, Edelman ER. Cells in Fluidic Environments are Sensitive to Flow Frequency. Journal of Cellular Physiology. 2005 Feb 7; 204: 329-335. [PDF]
2004

  • Schwartz RS, Edelman ER, Carter A, Chronos NA, Rogers C, Robinson KA, Waksman R, Machan L,Weinberger J, Wilensky RL, Goode JL, Hottenstein OD, Zuckerman BD, Virmani R. Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation. 2004 Oct 19;110(16):2498-505.
  • Kolandaivelu K, Edelman ER. Environmental influences on endovascular stent platelet reactivity: An in vitro comparison of stainless steel and gold surfaces. Journal of Biomedical Materials Research. 2004 Aug 1;70A(2):186-93.
  • Levin AD, Vukmirovic N, Hwang CW, Edelman ER. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proceedings of the National Academy of Sciences USA. 2004 Jun 22;101(25):9463-7.
  • Richter Y, Groothuis A, Seifert P, Edelman ER. Dynamic flow alterations dictate leukocyte adhesion andresponse to endovascular interventions. Journal of Clinical Investigations. 2004 Jun;113(11):1607-14.
  • Tzafriri AR, Wu D, Edelman ER. Analysis of compartmental models of ligand-induced endocytosis . Journal of Theoretical Biology. 2004 Jun 21; 229: 127-138.
  • Sapp JL, Cooper JM, Soejima K, Sorrell T, Lopera G, Satti SD, Koplan BA, Epstein LM, Edelman E, Rogers C, Stevenson WG. Deep Myocardial Ablation Lesions Can Be Created with a Retractable Needle-Tipped Catheter. Pacing Clin Electrophysiol. 2004 May;27(5): 594-599.
  • Rogers C, Huynh R, Seifert PA, Chevalier B, Schofer J, Edelman ER, Toegel G, Kuchela A, Woupio A, Kuntz RE, Macon ND. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation. 2004 Apr13;109(14):1735-40.
  • Wu D, Edelman ER. Resonance Energy Transfer for Assessing the Molecular Integrity of Proteins for Local Delivery. Biotechnology and Bioengineering. 2004 Feb 20; 85(4): 406-412.
  • Tzafriri AR, Edelman ER. The Total Quasi-Steady State Approximation is Valid for Reversible Enzyme Kinetics . Journal of Theoretical Biology. 2004 Feb 7; 226: 301-311.
2003

  • Danenberg HD, Golomb G, Groothuis A, Gao J, Epstein H, Swaminathan RV, Seifert P, Edelman ER. Liposomal Alendronate Inhibits Systemic Innate Immunity and Reduces In-Stent NeointimalHyperplasia in Rabbits. Circulation. 2003 Dec 2; 108(22):2798-2804.
  • Janicki C, Hwang CW, Edelman ER. Dose model for stent-based delivery of a radioactive compound for the treatment of restenosis in coronary arteries. Medical Physics. 2003 Oct; 30(10): 2622-2628.
  • Stultz CM, Edelman ER. A structural model that explains the effects of hyperglycemia on collagenolysis. Biophysical Journal. 2003 Oct; 85(4):2198-2204.
  • Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, Fay WP, Simon DI, Edelman ER. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation. 2003 Aug 5;108(5):512-5.
  • Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P, Rogers C. Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vascular Medicine. 2003;8(1):17.
  • Edelman ER, Danenberg HD. Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds? Circulation. 2003 Jul 8;108(1):6-8.
  • Nugent HM, Edelman ER. Tissue engineering therapy for cardiovascular disease. Circulation Research. 2003 May 30;92(10):1068-78.
  • Hwang CW, Wu D, Edelman ER. Impact of transport and drug properties on the local pharmacology of drug-eluting stents. International Journal of Cardiovascular Interventions. 2003;5(1):7-12.
2002

  • Kolandaivelu K, Edelman ER. Low background, pulsatile, in vitro flow circuit for modeling coronary implant thrombosis. Journal of Biomechanical Engineering.2002 Dec;124(6):662-8.
  • Nugent HM, Groothuis A, Seifert P, Guerraro JL, Nedelman M, Mohanakumar T, Edelman ER. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. Journal of Vascular Research. 20 Nov-Dec; 39(6):524-33.
  • Stultz CM, Levin AD, Edelman ER. Phosphorylation-induced conformational changes in a mitogen-activated protein kinase substrate. Implications for tyrosine hydroxylase activation. Journal of Biological Chemistry. 2002 Dec 6;277(49):47653-61.
  • Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arteriosclerosis, Thrombosis and Vascular Biology. 2002 Nov 1;22(11): 1769-76.
  • Schwartz RS, Edelman ER, Carter A, Chronos N, Rogers C, Robinson KA, Waksman R, Weinberger J, Wilensky RL, Jensen DN, Zuckerman BD, Virmani R. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group.. Circulation 2002 Oct 1;106(14):1867-73.
  • Lewis EF, Edelman ER. Acute ST depressions in a patient with idiopathic hypertrophic subaortic stenosis and normal coronary arteries. Circulation 2002 Aug 6;106(6):757-8.
  • Danenberg HD, Welt FG, Walker M 3rd, Seifert P, Toegel GS, Edelman ER. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation. 2002 Jun 18. 105(24): 2917-22.
  • Balcells M, Edelman ER. Effect of Pre-Adsorbed Proteins on Attachment, Proliferation, and Function of Endothelial Cells. Journal of Cellular Physiology. 2002 May. 191: 155-161.
  • Hwang CW, Edelman ER. Arterial ultrastructure influences transport of locally delivered drugs. Circulation Research. 2002 Apr 19. 90(7): 826-832.
  • Welt FG, Horvath C, Nedelman M, Rao P, Rogers C. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circulation Research. 2002 Mar 8; 90(4): 488-94.
  • Woods TC, Blystone CR, Yoo J, Edelman ER. Activation of EphB2 and its ligands promote vascular smooth muscle cell proliferation. Journal of Biological Chemistry. 2002 Jan 18. 277(3): 1924-7.
2001

  • Welt FG, Woods TC, Edelman ER. Oral Heparin Prevents Neointimal Hyperplasia After Arterial Injury: Inhibitory Potential Depends on Type of Vascular Injury. Circulation. 2001 Dec 18. 104(25): 3121-3124.
  • Edelman ER. On Causes: Hippocrates, Aristotle, Robert Koch, and the Dread Pirate Roberts. Circulation. 2001 Nov 20. 104(21): 2509- 2512.
  • Lovich MA, Creel CJ, Hong K, Hwang CW, Edelman ER. Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel. Journal of Pharmaceutical Sciences. 2001 Sep. 90(9): 1324-1335.
  • Nugent HM, Edelman ER. Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. Journal of Surgical Research. 2001 Aug. 99(2): 228-34.
  • Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation. 2001 Jul 31. 104(5): 600-605.
  • Consi TR, Seifert PA, Triantafyllou MS, Edelman ER. The dorsal fin engine of the seahorse (Hippocampus sp.). Journal of Morphology. 2001 Apr. 248(1): 80-97.
  • Edelman ER, Seifert P, Groothuis A, Morss A, Bornstein D, Rogers C. Gold-coated NIR stents in porcine coronary arteries. Circulation. 2001 Jan 23. 103(3): 429-434.
2000

  • Welt FG, Edelman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arteriosclerosis, Thrombosis and Vascular Biology. 2000 Dec. 20(12): 2553-2558.
  • Drachman DE, Edelman ER, Seifert P, Groothuis AR, Bornstein DA, Kamath KR, Palasis M, Yang D, Nott SH, Rogers C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. Journal of the American College of Cardiology. 2000 Dec. 36(7): 2325-2332.
  • Edelman ER, Nathan A, Katada M, Gates J, Karnovsky MJ. Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials. 2000 Nov. 21(22): 2279-2286.
  • Elmalak O, Lovich MA, Edelman E. Correlation of transarterial transport of various dextrans with their physicochemical properties. Biomaterials. 2000 Nov. 21(22): 2263-2272.
  • Parikh SA, Edelman ER. Endothelial cell delivery for cardiovascular therapy. Advanced Drug Delivery Reviews. 2000 Aug 20. 42(1-2): 139-161. Review.
  • Ettenson DS, Koo EW, Januzzi JL, Edelman ER. Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth. Journal of Cellular Physiology. 2000 Jul. 184(1): 93-100.
  • Nugent MA, Nugent HM, Iozzo RV, Sanchack K, Edelman ER. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proceedings of the National Academy of Sciences U S A. 2000 Jun 6. 97(12): 6722-6727.
  • Tavakkolizadeh A, Shen R, Abraham P, Kormi N, Seifert P, Edelman ER, Jacobs DO, Zinner MJ, Ashley SW, Whang EE. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. Journal of Surgical Research. 2000 Jun 1. 91(1): 77-82.
  • Creel CJ, Lovich MA, Edelman ER. Arterial paclitaxel distribution and depostion. Circulation Research. 2000 Apr 28. 86(8):879-884.
  • Garasic JM, Edelman ER, Squire JC, Seifert P, Williams MS, Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation. 2000 Feb 22. 101(7): 812-8.
  • Simon DI, Dhen Z, Seifert P, Edelman ER, Ballantyne CM, Rogers C. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. Journal of Clinical Investigation. 2000 Feb. 105(3): 293-300.
  • Noh I, Lovich MA, Edelman ER. Mechanisms of heparin transport through expanded poly(tetrafluoroethylene) vascular grafts. Journal of Biomedical Materials Research. 2000 Jan. 49(1): 112-9.s
CBSET, Inc
info@cbset.org